Epigenetics
Global Reorganization of Replication Domains During Embryonic Stem Cell Differentiation
07/10/2008
Microscopy studies have suggested that chromosomal
DNA is composed of multiple, megabase-sized segments,
each replicated at different times during S-phase of
the cell cycle. However, a molecular definition of
these coordinately replicated sequences and the
stability of the boundaries between them has not been
established. We constructed genome-wide
replication-timing maps in mouse embryonic stem
cells, identifying multimegabase coordinately
replicated chromosome segments—“replication
domains”—separated by remarkably distinct temporal
boundaries. These domain boundaries were shared
between several unrelated embryonic stem cell lines,
including somatic cells reprogrammed to pluripotency
(so-called induced pluripotent stem cells). However,
upon differentiation to neural precursor cells,
domains encompassing approximately 20% of the genome
changed their replication timing, temporally
consolidating into fewer, larger replication domains
that were conserved between different neural
precursor cell lines. Domains that changed
replication timing showed a unique sequence
composition, a strongly biased directionality for
changes in resident gene expression, and altered
radial positioning within the three-dimensional space
in the cell nucleus, suggesting that changes in
replication timing are related to the reorganization
of higher-order chromosome structure and function
during differentiation. Moreover, the property of
smaller discordantly replicating domains may define a
novel characteristic of pluripotency.
PLoS Biol 6(10): e245 doi:10.1371/journal.pbio.0060245
PLoS Biol 6(10): e245 doi:10.1371/journal.pbio.0060245
|
An Sp1/Sp3 Binding Polymorphism Confers Methylation Protection
28/08/2008
The factors that guide DNA hypermethylation in cancer
are poorly understood. We identified the candidate
tumor-suppressor gene, RIL, as a frequent methylation
target in cancer. Here, we report on a 12-bp
polymorphic sequence around its transcription start
site that creates a long allele. Methylation analysis
showed that, in aging colon, colon cancer, and
leukemias, the short allele had 2.1–3.1-fold higher
methylation than the long allele (P<0.001). Short
and long alleles had similar expression levels in
EBV-transformed cell lines. Electrophorectic mobility
shift assay showed that the inserted region of the
long allele binds Sp1 and Sp3 transcription factors.
Transfection of RIL allele-specific transgenes showed
no effects of the additional Sp1 site on
transcription early on, but methylation-seeded
constructs showed gradually decreasing transcription
from the short allele with eventual spreading of de
novo methylation. By contrast, the long allele showed
stable expression over time as measured by
luciferase, and ~2–3-fold lower levels of methylation
by bisulfite sequencing (P<0.001), suggesting that
the polymorphic Sp1 site protects against
time-dependent silencing. Our finding demonstrates
that in some genes, hypermethylation in cancer is
dictated by protein-DNA interactions at the promoters
and provides a novel mechanism by which genetic
polymorphisms can influence an epigenetic state.
PLoS Genet 4(8): e1000162. doi:10.1371/journal.pgen.1000162
PLoS Genet 4(8): e1000162. doi:10.1371/journal.pgen.1000162
S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons
28/08/2008
Brain-derived neurotrophic factor (BDNF) and other
neurotrophins have a vital role in the development of
the rat and mouse nervous system by influencing the
expression of many specific genes that promote
differentiation, cell survival, synapse formation
and, later, synaptic plasticity1. Although nitric
oxide (NO) is known to be an important mediator of
BDNF signalling in neurons2, the mechanisms by which
neurotrophins influence gene expression during
development and plasticity remain largely unknown.
Here we show that BDNF triggers NO synthesis and
S-nitrosylation of histone deacetylase 2 (HDAC2) in
neurons, resulting in changes to histone
modifications and gene activation. S-nitrosylation of
HDAC2 occurs at Cys 262 and Cys 274 and does not
affect deacetylase activity. In contrast,
nitrosylation of HDAC2 induces its release from
chromatin, which increases acetylation of histones
surrounding neurotrophin-dependent gene promoters and
promotes transcription. Notably, nitrosylation of
HDAC2 in embryonic cortical neurons regulates
dendritic growth and branching, possibly by the
activation of CREB
(cyclic-AMP-responsive-element-binding
protein)-dependent genes. Thus, by stimulating NO
production and S-nitrosylation of HDAC2, neurotrophic
factors promote chromatin remodelling and the
activation of genes that are associated with neuronal
development.
Nature advance online publication 27 August 2008 | doi:10.1038/nature07238
Nature advance online publication 27 August 2008 | doi:10.1038/nature07238
Epigenetic Reprogramming by Adenovirus e1a
22/08/2008
Adenovirus e1a induces quiescent human cells to
replicate. We found that e1a causes global
relocalization of the RB (retinoblastoma) proteins
(RB, p130, and p107) and p300/CBP histone
acetyltransferases on promoters, the effect of which
is to restrict the acetylation of histone 3 lysine-18
(H3K18ac) to a limited set of genes, thereby
stimulating cell cycling and inhibiting antiviral
responses and cellular differentiation. Soon after
expression, e1a binds transiently to promoters of
cell cycle and growth genes, causing enrichment of
p300/CBP, PCAF (p300/CBP-associated factor), and
H3K18ac; depletion of RB proteins; and
transcriptional activation. e1a also associates
transiently with promoters of antiviral genes,
causing enrichment for RB, p130, and H4K16ac;
increased nucleosome density; and transcriptional
repression. At later times, e1a and p107 bind mainly
to promoters of development and differentiation
genes, repressing transcription. The temporal order
of e1a binding requires its interactions with
p300/CBP and RB proteins. Our data uncover a defined
epigenetic reprogramming leading to cellular
transformation.
Science 22 August 2008: Vol. 321. no. 5892, pp. 1086 - 1088, DOI: 10.1126/science.1155546
Science 22 August 2008: Vol. 321. no. 5892, pp. 1086 - 1088, DOI: 10.1126/science.1155546
Genome-scale DNA methylation maps of pluripotent and differentiated cells
07/08/2008
DNA methylation is essential for normal development1,
2, 3 and has been implicated in many pathologies
including cancer4, 5. Our knowledge about the
genome-wide distribution of DNA methylation, how it
changes during cellular differentiation and how it
relates to histone methylation and other chromatin
modifications in mammals remains limited. Here we
report the generation and analysis of genome-scale
DNA methylation profiles at nucleotide resolution in
mammalian cells. Using high-throughput reduced
representation bisulphite sequencing6 and
single-molecule-based sequencing, we generated DNA
methylation maps covering most CpG islands, and a
representative sampling of conserved non-coding
elements, transposons and other genomic features, for
mouse embryonic stem cells,
embryonic-stem-cell-derived and primary neural cells,
and eight other primary tissues. Several key findings
emerge from the data. First, DNA methylation patterns
are better correlated with histone methylation
patterns than with the underlying genome sequence
context. Second, methylation of CpGs are dynamic
epigenetic marks that undergo extensive changes
during cellular differentiation, particularly in
regulatory regions outside of core promoters. Third,
analysis of embryonic-stem-cell-derived and primary
cells reveals that 'weak' CpG islands associated with
a specific set of developmentally regulated genes
undergo aberrant hypermethylation during extended
proliferation in vitro, in a pattern reminiscent of
that reported in some primary tumours. More
generally, the results establish reduced
representation bisulphite sequencing as a powerful
technology for epigenetic profiling of cell
populations relevant to developmental biology, cancer
and regenerative medicine.
Nature 454, 766-770 (7 August 2008) | doi:10.1038/nature07107; Received 24 March 2008; Accepted 21 May 2008; Published online 6 July 2008
Nature 454, 766-770 (7 August 2008) | doi:10.1038/nature07107; Received 24 March 2008; Accepted 21 May 2008; Published online 6 July 2008
Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development
07/08/2007
The hypothesis of fetal origins of adult disease
posits that early developmental exposures involve
epigenetic modifications, such as DNA methylation,
that influence adult disease susceptibility. In utero
or neonatal exposure to bisphenol A (BPA), a
high-production-volume chemical used in the
manufacture of polycarbonate plastic, is associated
with higher body weight, increased breast and
prostate cancer, and altered reproductive function.
This study shows that maternal exposure to this
endocrine-active compound shifted the coat color
distribution of viable yellow agouti (A vy) mouse
offspring toward yellow by decreasing CpG
(cytosine-guanine dinucleotide) methylation in an
intracisternal A particle retrotransposon upstream of
the Agouti gene. CpG methylation also was decreased
at another metastable locus, the CDK5
activator-binding protein (Cabp IAP). DNA methylation
at the A vy locus was similar in tissues from the
three germ layers, providing evidence that epigenetic
patterning during early stem cell development is
sensitive to BPA exposure. Moreover, maternal dietary
supplementation, with either methyl donors like folic
acid or the phytoestrogen genistein, negated the DNA
hypomethylating effect of BPA. Thus, we present
compelling evidence that early developmental exposure
to BPA can change offspring phenotype by stably
altering the epigenome, an effect that can be
counteracted by maternal dietary supplements.
PNAS August 7, 2007 vol. 104 no. 32 13056-13061
PNAS August 7, 2007 vol. 104 no. 32 13056-13061

